You have 9 free searches left this month | for more free features.

HIV resistance

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

New Treatment Strategies in Eastern European Region and in

Recruiting
  • HIV-1-infection
    • Cologne, Germany
    • +3 more
    Nov 10, 2023

    Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction

    Not yet recruiting
    • Hiv
    • +5 more
    • differences in CD4 reconstruction
    • (no location specified)
    Sep 17, 2023

    Mycoplasma Genitalium Infection and Associated Antimicrobial

    Not yet recruiting
    • STI
    • Mycoplasma Genitalium Infection
    • self-sampling kits for STI testing in the laboratory
    • Hong Kong, Hong Kong, China, Hong Kong
      The Chinese University of Hong Kong
    Mar 16, 2023

    HIV-1-infection Trial in Barcelona (Doravirine 100Mg Tab)

    Not yet recruiting
    • HIV-1-infection
    • Doravirine 100Mg Tab
    • Barcelona, Spain
      Hospital Clinic i Provincial de Barcelona
    Aug 17, 2022

    HIV, Drug Resistance, Drug Drug Interaction Trial in Switzerland (DOR/DTG/3TC)

    Not yet recruiting
    • HIV
    • +2 more
    • Basel, Switzerland
    • +6 more
    Sep 7, 2023

    Digestive Microbiota in Adults Living With HIV-1

    Withdrawn
    • HIV
    • Stool sample collection
    • Blood sample collection
    • Montpellier, France
    • +1 more
    Feb 9, 2023

    Methamphetamine Abuse, Hiv, Social Stigma Trial (Methamphetamine, PrEP, and Intersectional Stigma (eMPrISe) study)

    Not yet recruiting
    • Methamphetamine Abuse
    • +2 more
    • Methamphetamine, PrEP, and Intersectional Stigma (eMPrISe) study
    • (no location specified)
    Mar 24, 2023

    HIV/AIDS Trial in Elandsdoorn (Intensified monitoring, Standard of care monitoring)

    Completed
    • HIV/AIDS
    • Intensified monitoring
    • Standard of care monitoring
    • Elandsdoorn, Limpopo, South Africa
      Ndlovu Medical Centre
    May 10, 2022

    HIV, Insulin Resistance, Food Insecurity Trial (NOURISH Food Box)

    Not yet recruiting
    • HIV
    • +2 more
    • NOURISH Food Box
    • (no location specified)
    Jan 25, 2022

    Large Scale Transition toDolutegravir-based First-line ART in

    Not yet recruiting
    • HIV Infections
      • Abidjan, Côte D'Ivoire
      • +2 more
      Mar 28, 2022

      HIV-1-infection Trial in Johannesburg (Doravirine/Lamivudine/Tenofovir)

      Recruiting
      • HIV-1-infection
      • Johannesburg, Gauteng, South Africa
      • +2 more
      Jun 6, 2022

      HIV, AIDS Trial in Durban, Mbarara (HIV-1 RNA Resistance Testing)

      Completed
      • HIV
      • AIDS
      • HIV-1 RNA Resistance Testing
      • Durban, South Africa
      • +1 more
      Mar 28, 2022

      HIV/AIDS Trial in Masaka (Intensive Adherence Counselling (IAC))

      Not yet recruiting
      • HIV/AIDS
      • Intensive Adherence Counselling (IAC)
      • Masaka, Uganda
        Kalisizo Hospital
      Aug 22, 2022

      Primary Resistance in HIV Patients in Colombia

      Recruiting
      • HIV Infection
      • HIV-1 plasma RNA Genotyping secuencing by Sanger technique
      • HIV-1 plasma RNA Genotyping secuencing by Ultra-deep sequencing technique
      • Cali, Valle, Colombia
        REVIVA, Red de VIH del Valle del Cauca
      Jan 17, 2022

      HIV-1-infection Trial in Saint Louis (Biktarvy Tab)

      Terminated
      • HIV-1-infection
      • Biktarvy Tab
      • Saint Louis, Missouri
        Southampton Healthcare, Inc.
      Jan 3, 2023

      HIV, Insulin Sensitivity, Diabetes Trial in Gaborone (Zidovudine, Nevirapine)

      Completed
      • HIV
      • +2 more
      • Gaborone, Botswana
        Botswana-Harvard AIDS Institute Partnership
      Jul 18, 2022

      Human Immunodeficiency Virus, Metabolic Syndrome Trial run by the NIAID (Intermittent fasting, Standard of Care)

      Terminated
      • Human Immunodeficiency Virus
      • Metabolic Syndrome
      • Intermittent fasting
      • Standard of Care
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Dec 21, 2021

      HIV Trial in Spain (Dolutegravir 50 MG / Lamivudine 300 MG Oral Tablet [Dovato])

      Active, not recruiting
      • HIV Infections
      • Dolutegravir 50 MG / Lamivudine 300 MG Oral Tablet [Dovato]
      • Vigo, Pontevedra, Spain
      • +16 more
      Jun 20, 2022

      HIV-1-infection Trial in Lesotho, Tanzania (Clinical management informed by HIV-1 genotypic resistance testing)

      Active, not recruiting
      • HIV-1-infection
      • Clinical management informed by HIV-1 genotypic resistance testing
      • Seboche, Butha-Buthe, Lesotho
      • +9 more
      Dec 4, 2022

      Sexually Transmitted Infection, Chlamydia, Gonorrhea Trial (Point-of-care STI testing)

      Not yet recruiting
      • Sexually Transmitted Infection
      • +8 more
      • Point-of-care STI testing
      • (no location specified)
      Sep 12, 2022

      HIV Positive Trial in Maseno, Nairobi (Pre-ART Oligonucleotide Assay (OLA))

      Completed
      • HIV Positive
      • Pre-ART Oligonucleotide Assay (OLA)
      • Maseno, Kenya
      • +1 more
      Oct 18, 2021

      Frailty, Quality of Life, Physical Inactivity Trial in Madrid (Personalized multicomponent exercise program (strength,

      Active, not recruiting
      • Frailty
      • +3 more
      • Personalized multicomponent exercise program (strength, resistance, balance, and flexibility) (PMEP)
      • +2 more
      • Madrid, Spain
      • +1 more
      Jun 23, 2022

      Impact of V106I on Resistance to Doravirine

      Not yet recruiting
      • HIV-1-infection
      • Phenotypic resistance measure
      • (no location specified)
      Aug 17, 2021

      Dynamics of Drug Resistance-associated Mutations in HIV-1 DNA

      Recruiting
      • HIV-1-infection
      • Genotypic Resistance Test
      • Paris, France
        ARVD
      Jul 21, 2021

      HIV-1 Infection, Resistance, and Renal and Skeletal Adverse

      Completed
      • HIV
        • Foster City, California
          Gilead Sciences, Inc.
        Aug 27, 2021